Review PaperFactors impacting antiretroviral therapy adherence among human immunodeficiency virus–positive adolescents in Sub-Saharan Africa: a systematic review
Introduction
Acquired immunodeficiency syndrome is the main reason for death in African adolescents aged 10–19 years.1 Out of 2 million human immunodeficiency virus (HIV)-positive adolescents worldwide, 82% live in Sub-Saharan Africa (SSA).2 Adolescents acquire HIV either vertically from their mother or horizontally through sexual contact or risky behaviour.3
Although still incurable, HIV in SSA has changed from a ‘killer disease’ to a treatable chronic condition since paediatric antiretroviral therapy (ART) was introduced in SSA in 2004,4 leading to great improvements in survival and life quality among adolescents.5 But effective treatment outcomes depend on optimal ART adherence,6 where adherence refers to an individual's capability to take drugs at recommended times.7 In addition, ART dramatically reduces rates of onward HIV transmission.8 Public health strategies today are building on this to contain the epidemic. All HIV-positive pregnant women are given ART to prevent infection of babies.9 Countries are introducing ‘Test and Treat’ policies where all patients testing HIV-positive immediately start treatment.9 But low infectivity depends on optimal ART adherence, classified as at least 95% of doses expected to be used.10 Poor ART adherence can lead to treatment failure, disease progression, increased risk of transmission11 and healthcare costs.12, 13
According to Gulick,14 adherence varies over time, making frequent adherence assessments crucial. Assessments are performed either subjectively through patient or caregiver reports or objectively: pharmacologically through pill count or electronic measurement and physiologically through viral load tests. All methods have limitations and can lead to inaccurate estimates.15 Pill counts can be modified; verbal reports present an easily biased subjective result, and frequent viral load tests are often unaffordable in developing countries.16 Combining methods could improve accuracy.17
Today, HIV in SSA is a public health challenge: how to get millions of people in rural areas with poor health infrastructure to take daily medicines.18 The challenge is greatest for adolescents undergoing the physical, social and psychological changes of sexual maturity. Being HIV-positive adds to the complexity of difficulties faced by this group.19 While data on ART coverage and adherence are limited,10 studies suggest less than half of adolescents living with HIV (ALHIV) know their status and that adherence levels are suboptimal.10, 20 One study reported only 20.7% of adolescents achieve good adherence.20 ART adherence levels are poorer in ALHIV compared to adults.21, 22
The factors impacting ART adherence can be categorised according to the patient, the medication, the caregiver and the health system.23 Multiple factors are involved which may vary according to age, context, culture, health system, education and caregiver support.24 Some factors may be temporary, others permanent. Poverty, stigma, lack of social support, family disintegration, drug side-effects, weak health systems and disclosure of HIV status are cited as impacting adolescent ART adherence.25, 26, 27
Disclosure is defined as acquiring knowledge about one's HIV status28 or informing others about one's HIV status.29 Adolescents who do not know why they are taking medicines are more likely to miss doses, and those unable to tell their family and friends of their HIV status may need to hide their treatment, making adherence more difficult.30 Additionally, religious beliefs,31 described as ‘the belief in and worship of a superhuman controlling power’,32 and intimate relationships33 may play a role in ALHIV adhering to ART. Often ALHIV hide poor adherence from healthcare providers to avoid rejection.34, 35
With limited resources available, interventions need to be designed to address different contexts and continuously evaluated for effectiveness.25 Agwu and Fairlie36 found that interventions to promote disclosure and counselling facilitate adherence among ALHIV. HIV peer support groups were also mentioned as beneficial.37 However, strategies can only be improved through increased knowledge of the factors impacting ART adherence. Huge resources are spent on viral load tests to assess adherence clinically, but much less on interventions to address root causes of poor adherence.38
Several systematic reviews have been published regarding this topic for different age groups and contexts.39, 40, 41, 42, 43, 44, 45 This study differs from previous reviews by including both quantitative and qualitative data and exclusively within the SSA context, where HIV prevalence is the highest globally.
This systematic review aims to identify factors that enable and impede ART adherence among ALHIV in SSA; to build on the findings of previous reviews, it includes religious beliefs and intimate relationships as factors impacting ART adherence among ALHIV. Additionally, it intends to guide decision-makers involved in HIV programmes, service providers, researchers and the general population, making recommendations to improve adolescent adherence to ART in SSA.
Section snippets
Methods
The review was conducted between 3 June and 15 August 2016, as the final research project for an online Masters in Public Health at the University of Hertfordshire, UK. A systematic, all-language search including quantitative and qualitative studies that addressed factors impacting ART adherence in SSA ALHIV was performed.
Study characteristics
Characteristics of the 11 included studies are summarised in Table 1. Study countries were Congo (Democratic Republic), Ghana, Kenya, Rwanda, South Africa, Uganda, Zambia and Zimbabwe. Seven studies used a qualitative approach, three a mixed methods approach, and one a quantitative cross-sectional design. All qualitative studies used in-depth interviews, five used focus groups, one role play and one participant observation. The quantitative study used a cross-sectional design. Additional to the
Discussion
This systematic review identified 11 studies, representing 3407 participants in eight SSA countries.
The findings evidence a complicated web of factors influencing ALHIV adherence. In total, 44 barriers and 29 facilitators were identified. Most were patient-related, with stigma as the greatest barrier, followed by drug side-effects, forgetfulness, lack of caregiver support, not knowing the reason for taking the drugs, poverty, and depression. Important factors facilitating adherence were
Acknowledgements
The lead author gratefully acknowledges the help given by Tom Gibb in proof-reading the original project.
Ethical approval
None sought, as using secondary data.
Funding
None declared.
Competing interests
None declared.
References (102)
- et al.
HIV infection: Epidemiology, pathogenesis, treatment, and prevention
Lancet
(2014) - et al.
The end of AIDS: HIV infection as a chronic disease
Lancet
(2013) - et al.
Monitoring the response to antiretroviral therapy in resource-poor settings: the Malawi model
Trans R Soc Trop Med Hyg
(2004) - et al.
Perinatally acquired HIV infection in adolescents from sub-Saharan Africa: a review of emerging challenges
Lancet Infect Dis
(2014) - et al.
Rights-based services for adolescents living with HIV: adolescent self efficacy and implications for health systems in Zambia
Reprod Health Matters
(2013) - et al.
To say or Not to say: a qualitative study on the disclosure of their condition by human immunodeficiency virus-positive adolescents
J Adolesc Health
(2009) Adolescents are the outliers in the AIDS response
(2016)Estimated percentage of adolescents (aged 10–19) living with HIV, by region
(2016)Global HIV/AIDS response: epidemic update and health sector progress towards universal access
(2011)Medication adherence
(2009)
Prevention benefits of HIV treatment
Treat all people living with HIV, offer antiretrovirals as additional prevention choice for people at "substantial" risk
Current strategies for improving access and adherence to antiretroviral therapies in resource-limited settings
HIV/AIDS (Auckland, NZ)
Prevention of HIV-1 infection with early antiretroviral therapy
N Engl J Med
Adherence to highly active antiretroviral therapy assessed by pharmacy claims predicts survival in HIV-infected South African adults
J Acquir Immune Defic Syndr
Association of antiretroviral therapy adherence and health care costs
Ann Intern Med
Adherence to antiretroviral therapy: how much is enough?
Clin Infect Dis
Measuring adherence to antiretroviral treatment in resource-poor settings: the clinical validity of key indicators
BMC Health Serv Res
Limitations to treatment safety and efficacy - adherence to antiretroviral therapy
Antiretroviral drug adherence by HIV infected children attending Kericho District Hospital, Kenya
East Afr J Publ Health
Lessons from the field - mobile clinics for antiretroviral therapy in rural Mozambique
Bull World Health Organ
Considerations for antiretroviral use in special patient populations: HIV infected adolescents and young adults
Antiretroviral therapy adherence, virologic and immunologic outcomes in adolescents compared with adults in Southern Africa
J Acquir Immune Defic Syndr
Antiretroviral therapy outcomes among adolescents and youth in rural Zimbabwe
PLoS One
Factors associated with adherence to antiretroviral therapy among adolescents living with HIV/AIDS in low- and middle-income countries: a systematic review
AIDS Care
A qualitative assessment of barriers to antiretroviral therapy adherence among adolescents in Western Kenya
J HIV AIDS Soc Serv
Contemporary issues on the epidemiology and antiretroviral adherence of HIV-infected adolescents in sub-Saharan Africa: a narrative review
J Int AIDS Soc
Barriers to and facilitators of adherence to pediatric antiretroviral therapy in a sub Saharan setting: insights from a qualitative study
AIDS Patient Care STDS
Living situation affects adherence to combination antiretroviral therapy in HIV infected adolescents in Rwanda: a qualitative study
PLoS One
Disclosure of an HIV diagnosis to children: history, current research, and future directions
J Dev Behav Pediatr
I wish I could tell you but I can't: adolescents with perinatally acquired HIV and their dilemmas around self-disclosure
Clin Child Psychol Psychiatry
Disclosure of HIV status to children in resource-limited settings: a systematic review
J Int AIDS Soc
Religion and HIV in Tanzania: influence of religious beliefs on HIV stigma, disclosure, and treatment attitudes
BMC Publ Health
Botswana's positive adolescents: challenges of living with HIV
‘Children will always be children’: exploring perceptions and experiences of HIV-positive children who may not take their treatment and why they may not tell
Afr J AIDS Res
When information does not suffice: young people living with HIV and communication about ART adherence in the clinic
Vulnerable Child Youth Stud
Antiretroviral treatment, management challenges and outcomes in perinatally HIV-infected adolescents
J Int AIDS Soc
Adherence to antiretroviral therapy and retention in care for adolescents living with HIV from 10 districts in Uganda
BMC Infect Dis
Challenges and opportunities for the implementation of virological testing in resource-limited settings
J Int AIDS Soc
Service delivery interventions to improve adolescents' linkage, retention and adherence to antiretroviral therapy and HIV care
Trop Med Int Health
Adherence to antiretroviral therapy in adolescents living with HIV: systematic review and meta-analysis
AIDS
Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators
PLoS Med
Adherence to antiretroviral therapy for pediatric HIV infection: a qualitative systematic review with recommendations for research and clinical management
Pediatr
A systematic review of pediatric adherence to antiretroviral therapy in low- and middle-income countries
Pediatr Infect Dis J
A review of HIV antiretroviral adherence and intervention studies among HIV infected youth
Top Antivir Med
Review: an urgent need for research on factors impacting adherence to and retention in care among HIV positive youth and adolescents from key populations
J Int AIDS Soc
Determinants of antiretroviral adherence among HIV positive children and teenagers in rural Tanzania: a mixed methods study
BMC Infect Dis
Quality assessment tool for observational cohort and cross-sectional studies
Making sense of evidence
Cited by (132)
Agent-based Modeling: Exploring Treatment Adherence Among Adolescents with HIV
2023, Archives of Medical ResearchPredictors of Mortality among Children and Adolescents Living with HIV on Antiretroviral Therapy in Western Kenya
2024, Journal of Acquired Immune Deficiency SyndromesAidsimpact 2023: “We did more than survive”: lessons learned from studies of risk and resilience of young people growing up with HIV and mental health needs
2024, AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV